Clinicopathologic Study on Solid Pseudopapillary Neoplasm of the Pancreas
Qiwen BEN,Haixia CAO,Baiwen LI,Huafeng WANG,Yaozong YUAN,Jiancheng WANG
DOI: https://doi.org/10.3969/j.issn.1008-7125.2008.08.004
2008-01-01
Abstract:Background: Solid pseudopapillary neoplasm of the pancreas (SPNP) is not a rare pancreatic tumor with low malignant potential, and has been increasingly reported in recent years. Aims: To summarize the clinicopathologic characteristics and biological behaviour of SPNP. Methods: Clinicopathologic data of 13 cases of SPNP admitted from Jan. 2003 to Jun. 2007 in Shanghai Ruijin Hospital were analyzed retrospectively. Expressions of α1-antitrypsin (AT), α1-antichymotrypsin (ACT), neuronspecific enolase (NSE), vimentin, CD56, CDlO, insulin, glucagon, gastrin and somatostatin in tumor cells were determined by immunohistochemistry method. Results: Among 526 cases of pancreatic tumor, there were 13 patients (2.5%) diagnosed as having SPNP. The ratio of male to female in SPNP was 1:5.5, the median age was 31.5 years old. The median size of the tumors was 8.0 cm. Six SPNP patients (46.2%) were diagnosed by imaging examination before operation. Histologically, the tumors were composed of papillary and solid structures with uniform population of cells. Imageologically, the invasion of blood vessels and adjacent tissues were identified in 4 cases, and one of them presented hepatic metastasis. Immunohistochemistry examinations were positive for α1-AT, α1-ACT and vimentin in all 13 cases, NSE positive in 11 cases, but all were negative for insulin and gastrin. All of them underwent operations, and were followed up for a median period of 24 months without tumor recurrence or metastasis. Conclusions: SPNP is a tumor of low-grade malignancy mostly occurred in young adult females. Immunohistochemistry is very important for the diagnosis and differential diagnosis of SPNP. Surgical resection is curative for these patients.